By G HossainPosted on July 1, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The total of 52 mergers and acquisitions for the first half of 2026 reflects what analysts, industry watchers and executives are saying over and over: M&A is back. Biopharma strikes 50+ M&As deals in H1, led by Lilly’s $25B spend Post navigation In the blogs: Nothing like a World CupSentiment at BIO soars as FDA resets, dealmaking evolves; Amgen’s Tavneos in hot water
